President, Merck Research Labs Ventures Fund
Rez currently serves as President of MRL Ventures Fund, the global corporate venture arm of Merck research. Previously, he led Merck’s business development and licensing activities in Europe. He has also held management roles in large Pharma, private life-science companies and academia. He has served as a board member on numerous early and clinical stage companies. Rez received his B.Sc. and Ph.D. from Newcastle University, UK.